Keele, UK, 22 October 2007 - UK based Cobra Biomanufacturing Plc (AIM: CBF) has signed an agreement with North Brunswick, NJ based Advaxis (OTCBB: ADXS) to manufacture Phase II clinical trial material of a therapeutic cervical cancer vaccine known as Lovaxin C.
